AK Medical Holdings Limited (HKG:1789)
Hong Kong · Delayed Price · Currency is HKD 5.85
0.00 (0.00%)
May 29, 2026, 4:08 PM HKT
AK Medical Holdings Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,482 | 1,346 | 1,094 | 1,052 | 761.44 | |
Revenue Growth (YoY) | 10.11% | 23.09% | 3.98% | 38.16% | -26.46% |
Cost of Revenue | 585.04 | 538.18 | 419.38 | 415.61 | 262.25 |
Gross Profit | 897.4 | 808.19 | 674.49 | 636.44 | 499.19 |
Selling, General & Admin | 417.58 | 384.86 | 352.25 | 298.42 | 292.66 |
Research & Development | 136.02 | 139.21 | 137.13 | 110.87 | 113.07 |
Other Operating Expenses | -30.09 | -16.65 | -26.37 | -11.19 | -5.98 |
Operating Expenses | 523.52 | 507.41 | 463 | 398.09 | 399.75 |
Operating Income | 373.88 | 300.78 | 211.48 | 238.34 | 99.44 |
Interest Expense | -2.94 | -0.92 | -1.29 | -2.17 | -1.61 |
Interest & Investment Income | 29.39 | 23.37 | 22.77 | 17.75 | 8.99 |
Currency Exchange Gain (Loss) | -5.35 | -3.41 | -1.85 | 4.73 | 1.74 |
EBT Excluding Unusual Items | 394.98 | 319.82 | 231.12 | 258.65 | 108.56 |
Impairment of Goodwill | - | - | - | -18.36 | - |
Pretax Income | 394.98 | 319.82 | 231.12 | 240.29 | 108.56 |
Income Tax Expense | 55.89 | 45.9 | 49.01 | 35.52 | 15.94 |
Net Income | 339.09 | 273.93 | 182.1 | 204.77 | 92.62 |
Net Income to Common | 339.09 | 273.93 | 182.1 | 204.77 | 92.62 |
Net Income Growth | 23.79% | 50.42% | -11.07% | 121.09% | -70.50% |
Shares Outstanding (Basic) | 1,117 | 1,116 | 1,113 | 1,109 | 1,113 |
Shares Outstanding (Diluted) | 1,120 | 1,119 | 1,119 | 1,117 | 1,121 |
Shares Change (YoY) | 0.10% | -0.05% | 0.15% | -0.28% | 1.21% |
EPS (Basic) | 0.30 | 0.25 | 0.16 | 0.18 | 0.08 |
EPS (Diluted) | 0.30 | 0.24 | 0.16 | 0.18 | 0.08 |
EPS Growth | 24.18% | 52.50% | -11.11% | 125.00% | -71.43% |
Free Cash Flow | 290.31 | 298.25 | -149.86 | 127.72 | 117.86 |
Free Cash Flow Per Share | 0.26 | 0.27 | -0.13 | 0.11 | 0.10 |
Dividend Per Share | 0.106 | 0.068 | 0.041 | 0.053 | 0.020 |
Dividend Growth | 56.73% | 65.64% | -23.04% | 160.59% | -39.53% |
Gross Margin | 60.54% | 60.03% | 61.66% | 60.49% | 65.56% |
Operating Margin | 25.22% | 22.34% | 19.33% | 22.66% | 13.06% |
Profit Margin | 22.87% | 20.34% | 16.65% | 19.46% | 12.16% |
Free Cash Flow Margin | 19.58% | 22.15% | -13.70% | 12.14% | 15.48% |
EBITDA | 465.33 | 377.69 | 282.36 | 300.3 | 156.85 |
EBITDA Margin | 31.39% | 28.05% | 25.81% | 28.54% | 20.60% |
D&A For EBITDA | 91.45 | 76.91 | 70.88 | 61.95 | 57.42 |
EBIT | 373.88 | 300.78 | 211.48 | 238.34 | 99.44 |
EBIT Margin | 25.22% | 22.34% | 19.33% | 22.66% | 13.06% |
Effective Tax Rate | 14.15% | 14.35% | 21.21% | 14.78% | 14.68% |